Home   Logon   Mobile Site   Research and Commentary   About Us   Call 1.800.621.1675 or Email Us       Follow Us: 

Search by Ticker, Keyword or CUSIP       
 
 


 

Sabrient Baker's Dozen Portfolio, 4th Quarter 2021 Series
Ticker Symbol: FLTYXX

13 Holdings (As of Day of Deposit)
Ticker Company Name Initial
Weight
Price*
Consumer Discretionary (23.08%):
TMHC Taylor Morrison Home Corporation 7.69% $27.10
TJX The TJX Companies, Inc. 7.71% 63.90
BLD TopBuild Corp. 7.68% 221.61
Energy (15.37%):
DVN Devon Energy Corporation 7.68% 40.30
FANG Diamondback Energy, Inc. 7.69% 110.94
Financials (7.70%):
ACGL Arch Capital Group Ltd. 7.70% 42.07
Health Care (7.71%):
MRNA Moderna, Inc. 7.71% 333.61
Industrials (7.69%):
HRI Herc Holdings, Inc. 7.69% 181.61
Information Technology (15.36%):
AMAT Applied Materials, Inc. 7.69% 134.60
KLAC KLA Corporation 7.67% 332.14
Materials (23.09%):
NTR Nutrien Ltd. 7.70% 71.82
WLK Westlake Chemical Corporation 7.69% 100.70
WRK WestRock Company 7.70% 48.20

*As of the close of business on 10/19/21.
Market values are for reference only and are not indicative of your individual cost basis.


Not FDIC Insured • Not Bank Guaranteed • May Lose Value

Portfolio Summary
Initial Date of Deposit 10/20/2021
Initial Public Offering Price $10.00 per Unit
Portfolio Ending Date 1/20/2023
Cash CUSIP 30322C549
Reinvestment CUSIP 30322C556
Fee Accounts Cash CUSIP 30322C564
Fee Accounts Reinvestment CUSIP 30322C572

Sales Charges (based on a $10 public offering price)
Standard Accounts
Transactional Sales Charges: Initial: 0.00%
  Deferred: 1.35%
Creation and Development Fee:   0.50%
Maximum Sales Charge:   1.85%
Fee/Wrap Accounts
Maximum Sales Charge:   0.50%

The deferred sales charge will be deducted in three monthly installments commencing 1/20/22.

When the public offering price is less than or equal to $10.00 per unit, there will be no initial sales charge. If the price exceeds $10.00 per unit, you will pay an initial sales charge.

The maximum sales charge for investors in fee accounts consists of the C&D fee. Investors in fee accounts are not assessed any transactional sales charges. Standard accounts sales charges apply to units purchased as an ineligible asset.

The C&D fee is a charge of $0.050 per unit collected at the end of the initial offering period. If the price you pay exceeds $10 per unit, the C&D fee will be less than 0.50%; if the price you pay is less than $10 per unit, the C&D fee will exceed 0.50%.

In addition to the sales charges listed, UITs are subject to annual operating expenses and organization costs.

You should consider the portfolio's investment objectives, risks, and charges and expenses carefully before investing. Contact your financial professional or call First Trust Portfolios L.P. at 1.800.621.1675 to request a prospectus, which contains this and other information about the portfolio. Read it carefully before you invest.

Risk Considerations
An investment in this unmanaged unit investment trust should be made with an understanding of the risks involved with owning common stocks, such as an economic recession and the possible deterioration of either the financial condition of the issuers of the equity securities or the general condition of the stock market.

An investment in foreign securities should be made with an understanding of the additional risks involved with foreign issuers, such as currency and interest rate fluctuations, nationalization or other adverse political or economic developments, lack of liquidity of certain foreign markets, withholding, the lack of adequate financial information, and exchange control restrictions impacting foreign issuers.

An investment in a portfolio containing small-cap and mid-cap companies is subject to additional risks, as the share prices of small-cap companies and certain mid-cap companies are often more volatile than those of larger companies due to several factors, including limited trading volumes, products, financial resources, management inexperience and less publicly available information.

Large capitalization companies may grow at a slower rate than the overall market.

As the use of Internet technology has become more prevalent in the course of business, the trust has become more susceptible to potential operational risks through breaches in cybersecurity.

The COVID-19 global pandemic has caused significant volatility and declines in global financial markets, causing losses for investors. The development of vaccines has slowed the spread of the virus and allowed for the resumption of “reasonably” normal business activity in the United States, although many countries continue to impose lockdown measures. Additionally, there is no guarantee that vaccines will be effective against emerging variants of the disease.

The value of the securities held by the trust may be subject to steep declines or increased volatility due to changes in performance or perception of the issuers.

Although this portfolio terminates in approximately 15 months, the strategy is long-term. Investors should consider their ability to pursue investing in successive portfolios, if available. There may be tax consequences unless units are purchased in an IRA or other qualified plan.

 
Fund Cusip Information
30322C549 (Cash)
30322C556 (Reinvest)
30322C564 (Cash-Fee)
30322C572 (Reinvest-Fee)
Printer Friendly Page Printer Friendly Page
 
The information presented is not intended to constitute an investment recommendation for, or advice to, any specific person. By providing this information, First Trust is not undertaking to give advice in any fiduciary capacity within the meaning of ERISA, the Internal Revenue Code or any other regulatory framework. Financial professionals are responsible for evaluating investment risks independently and for exercising independent judgment in determining whether investments are appropriate for their clients.
First Trust Portfolios L.P.  Member SIPC and FINRA. (Form CRS)   •  First Trust Advisors L.P. (Form CRS)
Home |  Important Legal Information |  Privacy Policy |  California Privacy Policy |  Business Continuity Plan |  FINRA BrokerCheck
Copyright © 2021 All rights reserved.